Marc Koska’s solution to the syringe safety problem has the potential to greatly improve how pharma companies fill-finish medicines and vaccines around the world. Read Marc’s amazing journey.
June 9, 2021
The ApiJect Story
Might interest you
View All
Global Health
Field Research Executive Summary – October 2025
Flora Koska, on the ApiLabs Field Research Network team, recently conducted a field research exercise in India to gathering user feedback on the latest Apiject prefilled injection device for delivery of injectable contraceptives. Read the report here.
Global Health
Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled Drug Delivery Platforms, Upcoming Webinar Hosted by Xtalks
Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint News provided by Xtalks l Feb 10, 2025, 08:30 ET In this free webinar, learn about...
Global Health
Affordable Prefilled Devices Greatly Expand Access
At Apiject, we believe a higher level of universal expanded access can be achieved by providing injectable medicine and vaccines in single-use, prefilled injectors that are simple, affordable, and can overcome many “Last Mile” challenges.